NASDAQ:ALXO | Free Cash Flow | ALX ONCOLOGY HOLDINGS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$18.65M$50,000.00-$18.7M
2025-12-31-$18.98M$49,000.00-$19.03M
2025-03-31-$24.66M$60,000.00-$24.72M
2024-12-31-$32.05M$60,000.00-$32.11M
2024-03-31-$37.92M$148,000.00-$38.07M
2023-12-31-$39.68M$148,000.00-$39.83M
2023-03-31-$27.82M$690,000.00-$28.51M
2022-12-31-$20.67M$389,000.00-$21.06M
2022-03-31-$20.67M$589,000.00-$21.26M
2021-12-31-$17.49M$261,000.00-$17.75M
2021-03-31-$5.14M$7,000.00-$5.14M
2020-12-31-$13.62M$11,000.00-$13.63M
2020-03-31-$8.96M$10,000.00-$8.97M
2019-12-31-$2.87M-$62,000.00-$2.94M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$84.14M$212,000.00-$84.35M
2024-12-31-$121.91M$447,000.00-$122.36M
2023-12-31-$130.36M$1.27M-$131.64M
2022-12-31-$89.22M$1.43M-$90.65M
2021-12-31-$68.1M$666,000.00-$68.77M
2020-12-31-$38.29M$31,000.00-$38.32M
2019-12-31-$14.25M$353,000.00-$14.6M
2018-12-31-$13.19M$653,000.00-$13.84M